3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Rectal Neoplasms
1
Pilonidal Sinus
1
Pancreatic Neuroendocrine Tumors
1
Pancreatic Neoplasms
1
Pain
1
Neoplasms
1
Lung Neoplasms
1
Colorectal Neoplasms
1
Choledochal Cyst
1
Interventions
Fluorouracil
155
Oxaliplatin
133
Leucovorin
124
Capecitabine
90
Irinotecan
88
Radiotherapy
63
Bevacizumab
61
Cetuximab
38
Folfox protocol
25
Panitumumab
21
Neoadjuvant Therapy
21
Surgical Procedures, Operative
19
Chemotherapy, Adjuvant
15
Radiation
13
Floxuridine
13
Erlotinib Hydrochloride
13
Early Intervention, Educational
13
IFL protocol
11
Drug Therapy
11
Proctectomy
10
Magnetic Resonance Spectroscopy
10
Counseling
10
Surveys and Questionnaires
8
Sorafenib
8
Psychiatric Rehabilitation
8
Gene Expression Profiling
8
Radiotherapy, Intensity-Modulated
7
Immunohistochemistry
7
Gemcitabine
7
Celecoxib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Rectal Neoplasms
×
Conversion to Open Surgery
×
Clear all
NCT03683446
2018-09-25
NSQIPc
The Methodist Hospital Research Institute
Completed
31,795 enrolled